6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene

C116H108N16O4 — CID 157410439

IUPAC6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene
SMILESCC=CCc1ncc(-c2ccc3c(c2)COc2cc4c(cc2-3)CCc2[nH]c(CC=CC)nc2-4)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)COc2cc4c(ccc5[nH]c(CC=CC)nc54)cc2-3)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)OCc2cc4c(cc2-3)CCc2[nH]c(CC=CC)nc2-4)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)OCc2cc4c(ccc5[nH]c(CC=CC)nc54)cc2-3)[nH]1
InChIInChI=1S/C29H28N4O.C29H26N4O.C29H28N4O.C29H26N4O/c2*1-3-5-7-27-30-16-25(32-27)19-9-11-21-20(13-19)17-34-26-15-22-18(14-23(21)26)10-12-24-29(22)33-28(31-24)8-6-4-2;2*1-3-5-7-27-30-16-25(32-27)19-9-11-21-22-13-18-10-12-24-29(33-28(31-24)8-6-4-2)23(18)14-20(22)17-34-26(21)15-19/h3-6,9,11,13-16H,7-8,10,12,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9-16H,7-8,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9,11,13-16H,7-8,10,12,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9-16H,7-8,17H2,1-2H3,(H,30,32)(H,31,33)
InChIKeyBOFKHPNEXBEPKS-UHFFFAOYSA-N
MW1790.25 g/mol
LogP26.53
Rot. Bonds20

About 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene

6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene (PubChem CID 157410439) has the molecular formula C116H108N16O4 and a molecular weight of 1790.25 g/mol. Its IUPAC name is 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene.

Molecular Properties

Compound Name6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene
PubChem CID157410439
Molecular FormulaC116H108N16O4
Molecular Weight1790.25 g/mol
Exact Mass1788.87
IUPAC Name6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene
SMILESCC=CCc1ncc(-c2ccc3c(c2)COc2cc4c(cc2-3)CCc2[nH]c(CC=CC)nc2-4)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)COc2cc4c(ccc5[nH]c(CC=CC)nc54)cc2-3)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)OCc2cc4c(cc2-3)CCc2[nH]c(CC=CC)nc2-4)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)OCc2cc4c(ccc5[nH]c(CC=CC)nc54)cc2-3)[nH]1
InChIInChI=1S/C29H28N4O.C29H26N4O.C29H28N4O.C29H26N4O/c2*1-3-5-7-27-30-16-25(32-27)19-9-11-21-20(13-19)17-34-26-15-22-18(14-23(21)26)10-12-24-29(22)33-28(31-24)8-6-4-2;2*1-3-5-7-27-30-16-25(32-27)19-9-11-21-22-13-18-10-12-24-29(33-28(31-24)8-6-4-2)23(18)14-20(22)17-34-26(21)15-19/h3-6,9,11,13-16H,7-8,10,12,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9-16H,7-8,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9,11,13-16H,7-8,10,12,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9-16H,7-8,17H2,1-2H3,(H,30,32)(H,31,33)
InChIKeyBOFKHPNEXBEPKS-UHFFFAOYSA-N
XLogP26.53
TPSA266.36 Ų
H-Bond Donors8
H-Bond Acceptors12
Rotatable Bonds20
Heavy Atoms136
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001790.25
LogP ≤ 526.53
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene?
The IUPAC name of 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene (CID 157410439) is 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene.
What is the SMILES notation for 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene?
The canonical SMILES for 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene is CC=CCc1ncc(-c2ccc3c(c2)COc2cc4c(cc2-3)CCc2[nH]c(CC=CC)nc2-4)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)COc2cc4c(ccc5[nH]c(CC=CC)nc54)cc2-3)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)OCc2cc4c(cc2-3)CCc2[nH]c(CC=CC)nc2-4)[nH]1.CC=CCc1ncc(-c2ccc3c(c2)OCc2cc4c(ccc5[nH]c(CC=CC)nc54)cc2-3)[nH]1.
What is the InChIKey of 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene?
The InChIKey is BOFKHPNEXBEPKS-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H28N4O.C29H26N4O.C29H28N4O.C29H26N4O/c2*1-3-5-7-27-30-16-25(32-27)19-9-11-21-20(13-19)17-34-26-15-22-18(14-23(21)26)10-12-24-29(22)33-28(31-24)8-6-4-2;2*1-3-5-7-27-30-16-25(32-27)19-9-11-21-22-13-18-10-12-24-29(33-28(31-24)8-6-4-2)23(18)14-20(22)17-34-26(21)15-19/h3-6,9,11,13-16H,7-8,10,12,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9-16H,7-8,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9,11,13-16H,7-8,10,12,17H2,1-2H3,(H,30,32)(H,31,33);3-6,9-16H,7-8,17H2,1-2H3,(H,30,32)(H,31,33).
What are the key properties of 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene?
6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene has a molecular weight of 1790.25 g/mol, XLogP of 26.53, 20 rotatable bonds, 8 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-20-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene;6-but-2-enyl-17-(2-but-2-enyl-1H-imidazol-5-yl)-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaene is sourced from PubChem (CID 157410439), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).